TABLE 3.

Study group characteristics

		Study Groups
		No Orlistat		Plus Orlistat
	Day	TAG (n = 11)	MAG (n = 11)	TAG (n = 12)	MAG (n = 11)
Age (years)	—	37.10 ± 7.2	42.4 ± 9.8	36.45 ± 10.3	42.3 ± 9.3
Weight (kg)a	0	91.4 ± 10.9	100.3 ± 12.3	101.7 ± 9.8	96.85 ± 10.1
	7	0.1 ± 1.2	0.3 ± 0.8	−0.6 ± 0.9	−0.05 ± 0.63
	14	0.7 ± 1.2	0.1 ± 0.9	−0.7 ± 1	0.03 ± 1.5
	21	0.2 ± 0.06	0.2 ± 1.0	−0.6 ± 1.1	0.1 ± 1.4
BMI (kg/m2)b	0	32.87 ± 3.1	36.04 ± 2.6	35.97 ± 3.4	35.05 ± 2.9
	7	0.08 ± 0.5	0.1 ± 0.32	−0.1 ± 0.33	−0.02 ± 0.23
	14	0.15 ± 0.5	0.04 ± 0.36	−0.16 ± 0.37	−0.09 ± 0.5
	21	0.14 ± 0.23	0.07 ± 0.38	−0.1 ± 0.4	0.04 ± 0.5
Total cholesterol (mmol/l)	0	5.28 ± 1.0	5.3 ± 0.87	5.05 ± 0.7	4.89 ± 0.81
HDL-C (mmol/l)	0	1.49 ± 0.4	1.47 ± 0.2	1.67 ± 9.7	1.32 ± 28
LDL-C (mmol/l)	0	3.26 ± 0.7	3.35 ± 0.7	2.86 ± 0.63	3.05 ± 0.47
Triglycerides (mmol/l)	0	1.16 ± 0.6	1.05 ± 0.3	1.14 ± 22	1.13 ± 43
EPA intake (mg/3 g oil)	—	505.2 ± 0.34	500 ± 0.75	505.2 ± 0.34	500 ± 0.75
DHA intake (mg/3 g oil)	—	316.8 ± 1.32	299.7 ± 0.86	316.8 ± 1.32	299.7 ± 0.86

Values represent mean ± SD. MAG refers to enriched sn-1(3)-MAG oil.

^aWeight change from baseline.

^bBMI percentage change from baseline.